FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W1604087868> ?p ?o ?g. }

• W1604087868 abstract "There is a paucity of data on the in vivo efficacy of antibiotics for lethal Vibrio species. Analyses of long-term surveillance datasets may provide insights into use of antibiotics to decrease mortality.The United States Centers for Disease Control and Prevention (CDC) Cholera and Other Vibrio Illness Surveillance (COVIS) dataset from 1990 to 2010, with 8056 records, was analysed to ascertain trends in antibiotics use and mortality.Two-thirds of patients (5243) were prescribed antibiotics - quinolones (56.1 %), cephalosporins (24.1 %), tetracyclines (23.5 %), and penicillins (15.4 %). Considering all Vibrio species, the only class of antibiotic associated with reduced odds of mortality was quinolone (odds ratio 0.56, 95 % CI 0.46-0.67). Patients with V. vulnificus treated according to CDC recommendations had lower mortality (quinolone alone: 16.7 %, 95 % CI 10.2-26.1; tetracycline plus cephalosporin: 21.7 %, 16.8-27.5; no antibiotic: 51.1 %, 45.6-56.7; each p < 0.001). Cephalosporin alone was associated with higher mortality (36.8 %, 28.2-46.3). For V. cholerae non-O1, non-O139, mortality rates were lower for quinolone (0 %, 0-2.0) or tetracycline (4.3 %, 1.2-14.5) compared to no antibiotic (9.3 %, 6.4-13.3). For all Vibrio species, mortality rates increased with number of antibiotics in the treatment regimen (p < 0.001). Treatment regimens that included quinolone were associated with lower mortality rates regardless of the number of antibiotics used. The main clinical syndromes of patients with V. vulnificus infection were septicaemia (53.1 %) and wound infections (30.6 %). Mortality among V. vulnificus patients with septicaemia was significantly higher than for other clinical syndromes (p < 0.001). In a multivariate regression model, mortality in cases with V. vulnificus was associated with presence of pre-existing conditions (ORs ranged from 4.52 to 10.30), septicaemia (OR 2.64, 95 % CI 1.92-3.63) and no antibiotic treatment (OR 7.89, 95 % CI 3.94-15.80).In view of the lack of randomized control trials, surveillance data may inform treatment decisions for potentially lethal Vibriosis. Considering all Vibrio species, use of quinolones is associated with lower mortality and penicillin alone is not particularly effective. For the most lethal species, V. vulnificus, treatment that includes either quinolone or tetracycline is associated with lower mortality than cephalosporin alone. We recommend treating patients who present with a clinical syndrome suggestive of V. vulnificus infection with a treatment regimen that includes a quinolone." @default.
• W1604087868 created "2016-06-24" @default.
• W1604087868 creator A5018103095 @default.
• W1604087868 creator A5040212380 @default.
• W1604087868 creator A5066100454 @default.
• W1604087868 creator A5068628806 @default.
• W1604087868 creator A5069822390 @default.
• W1604087868 date "2015-06-11" @default.
• W1604087868 modified "2023-10-11" @default.
• W1604087868 title "Antibiotic use for Vibrio infections: important insights from surveillance data" @default.
• W1604087868 cites W1974886846 @default.
• W1604087868 cites W1976798694 @default.
• W1604087868 cites W1987046928 @default.
• W1604087868 cites W1998616787 @default.
• W1604087868 cites W2000382033 @default.
• W1604087868 cites W2011283667 @default.
• W1604087868 cites W2028339881 @default.
• W1604087868 cites W2038021665 @default.
• W1604087868 cites W2044637793 @default.
• W1604087868 cites W2053705601 @default.
• W1604087868 cites W2066425473 @default.
• W1604087868 cites W2140055251 @default.
• W1604087868 cites W2141001286 @default.
• W1604087868 cites W2150732101 @default.
• W1604087868 cites W2154228854 @default.
• W1604087868 cites W2161428524 @default.
• W1604087868 cites W2318494470 @default.
• W1604087868 cites W2338907071 @default.
• W1604087868 cites W4242704650 @default.
• W1604087868 doi "https://doi.org/10.1186/s12879-015-0959-z" @default.
• W1604087868 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/4464855" @default.
• W1604087868 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26062903" @default.
• W1604087868 hasPublicationYear "2015" @default.
• W1604087868 type Work @default.
• W1604087868 sameAs 1604087868 @default.
• W1604087868 citedByCount "53" @default.
• W1604087868 countsByYear W16040878682016 @default.
• W1604087868 countsByYear W16040878682017 @default.
• W1604087868 countsByYear W16040878682018 @default.
• W1604087868 countsByYear W16040878682019 @default.
• W1604087868 countsByYear W16040878682020 @default.
• W1604087868 countsByYear W16040878682021 @default.
• W1604087868 countsByYear W16040878682022 @default.
• W1604087868 countsByYear W16040878682023 @default.
• W1604087868 crossrefType "journal-article" @default.
• W1604087868 hasAuthorship W1604087868A5018103095 @default.
• W1604087868 hasAuthorship W1604087868A5040212380 @default.
• W1604087868 hasAuthorship W1604087868A5066100454 @default.
• W1604087868 hasAuthorship W1604087868A5068628806 @default.
• W1604087868 hasAuthorship W1604087868A5069822390 @default.
• W1604087868 hasBestOaLocation W16040878681 @default.
• W1604087868 hasConcept C126322002 @default.
• W1604087868 hasConcept C156957248 @default.
• W1604087868 hasConcept C2778458500 @default.
• W1604087868 hasConcept C2779922871 @default.
• W1604087868 hasConcept C2780923616 @default.
• W1604087868 hasConcept C2781413609 @default.
• W1604087868 hasConcept C501593827 @default.
• W1604087868 hasConcept C523546767 @default.
• W1604087868 hasConcept C54355233 @default.
• W1604087868 hasConcept C64778159 @default.
• W1604087868 hasConcept C71924100 @default.
• W1604087868 hasConcept C86803240 @default.
• W1604087868 hasConcept C89423630 @default.
• W1604087868 hasConceptScore W1604087868C126322002 @default.
• W1604087868 hasConceptScore W1604087868C156957248 @default.
• W1604087868 hasConceptScore W1604087868C2778458500 @default.
• W1604087868 hasConceptScore W1604087868C2779922871 @default.
• W1604087868 hasConceptScore W1604087868C2780923616 @default.
• W1604087868 hasConceptScore W1604087868C2781413609 @default.
• W1604087868 hasConceptScore W1604087868C501593827 @default.
• W1604087868 hasConceptScore W1604087868C523546767 @default.
• W1604087868 hasConceptScore W1604087868C54355233 @default.
• W1604087868 hasConceptScore W1604087868C64778159 @default.
• W1604087868 hasConceptScore W1604087868C71924100 @default.
• W1604087868 hasConceptScore W1604087868C86803240 @default.
• W1604087868 hasConceptScore W1604087868C89423630 @default.
• W1604087868 hasIssue "1" @default.
• W1604087868 hasLocation W16040878681 @default.
• W1604087868 hasLocation W16040878682 @default.
• W1604087868 hasLocation W16040878683 @default.
• W1604087868 hasOpenAccess W1604087868 @default.
• W1604087868 hasPrimaryLocation W16040878681 @default.
• W1604087868 hasRelatedWork W1604087868 @default.
• W1604087868 hasRelatedWork W2086974394 @default.
• W1604087868 hasRelatedWork W2139597874 @default.
• W1604087868 hasRelatedWork W2365412452 @default.
• W1604087868 hasRelatedWork W2367586270 @default.
• W1604087868 hasRelatedWork W2410645540 @default.
• W1604087868 hasRelatedWork W2432904232 @default.
• W1604087868 hasRelatedWork W2772654151 @default.
• W1604087868 hasRelatedWork W2802146129 @default.
• W1604087868 hasRelatedWork W217093250 @default.
• W1604087868 hasVolume "15" @default.
• W1604087868 isParatext "false" @default.
• W1604087868 isRetracted "false" @default.
• W1604087868 magId "1604087868" @default.
• W1604087868 workType "article" @default.